In contrast, the expression of NUMB was observably elevated in cholangiocarcinoma (CHOL), esophageal carcinoma (ESCA), head and neck squamous cell carcinoma (HNSC), liver hepatocellular carcinoma (LIHC), and stomach adenocarcinoma (STAD), compared to normal controls. This evidence concerns the gene NUMB and cholangiocarcinoma.